Unichem is a research-driven pharmaceutical company dedicated to innovation and quality.
Each manufacturing site is closely integrated with Unichem's robust R&D infrastructure. This synergy ensures that new products are efficiently scaled from development to commercial production, maintaining consistency and quality across all batches. Over the years, Unichem has made substantial investments in Research and Development (R&D) to establish state-of-the-art facilities, evident in Unichem has made substantial investments in Research and Development (R&D) to establish state-of-the-art facilities, evident in Unichem's vast portfolio of high-quality medicines across all therapeutic categories in international regulated markets. Supported by a team of more than 300 highly qualified and trained scientists with exemplary credentials, the company’s R&D centers are equipped with cutting-edge pharmaceutical research technology.
Unichem has a comprehensive R&D division, continuously engaged in researching new products that meet the needs of the pharmaceutical market, with a focus on patient-centered care, innovation, and quality. The company's core strength lies in its ability to excel in developing generics and technologically complex products through innovation in formulations and analytical development. We prioritize innovation through a cost-effective, timely, and high-quality approach, embracing cutting-edge technology and constantly upgrading technological capabilities.
Unichem's R&D laboratories are equipped with the latest and most sophisticated formulation equipment and analytical instruments, such as ICPMS, XRPD, NMR, Raman Spectroscopy, in-situ fiber optic UV system for dissolution testing, LCMS, GCMS, DSC, particle size analyzer, IR/UV, TGA, HPLC, GC, laser drilling machine for osmotic controlled-release oral delivery systems (OROS), Wurster coating fluid bed systems, high shear wet granulation systems, dry granulation system (roller compaction), dual-layer tablet compression machine, semi-automated capsule filling machines, to name a few.
Unichem's R&D team is equipped with a specialized skill set and knowledge, along with state-of-the-art instrumentation related to Solid State Chemistry and Reverse Engineering. This enables scientifically sound solutions for highly complex projects in a time-efficient manner, giving Unichem a unique advantage over the general benchmark in the pharmaceutical industry.
Unichem's formulation research and development is well-versed in oral dosage forms such as tablets, capsules, powder for suspension, and syrups, covering a vast range of expertise including complex and differentiated generics, New Drug Delivery Systems (NDDS), platform technology, OROS, controlled/modified release dosage forms, and fixed-dose combinations. We specialize in developing complex and difficult-to-manufacture formulations, conceiving and implementing innovative concepts using the latest technologies, alongside our deep and diverse experience in engineering and formulations. We are constantly engaged with advanced technologies in manufacturing, measurement, analysis, and controls, as well as modeling and simulations to develop high-quality, affordable medicines in a time-efficient manner.
Unichem Unichem is focused and committed to providing the Brazilian Pharmaceutical Market with the best supply of affordable generic medications, exemplified by Unichem's ‘Dedicated’ Analytical and Formulation Research & Development Laboratory and team serving the Brazilian Market, where quality and innovation are built into the product from the design phase.
Unichem's API R&D department has expertise in Enantioselective Synthesis, Enzymatic Reactions, Coupling Chemistry, Green Chemistry, Hazardous Chemical Reactions, and Reactions involving Pyrophoric Reagents, ensuring the company's broad process development capabilities are better suited to meet the unique needs and goals of the Pharmaceutical Industry. We have a team of highly qualified specialists for route recognition and design to determine non-infringing, practically viable, and cost-effective synthetic routes for APIs and intermediates. We have a team of experienced chemical engineers and technology transfer chemists to transfer and scale up laboratory processes from milligrams to kilogram-scale production in factories, with full-scale validation support.
Unichem’s Intellectual Property Management Team is responsible for safeguarding Unichem's Intellectual Capital through drafting, filing, and processing patents; developing a non-infringing/first-to-market filing strategy; patent litigation, enforcement, and settlements.
Unichem's R&D is deeply rooted in the ideology of transforming innovation into operational excellence.
To strengthen its research capabilities in the fields of API Chemistry and Formulation, the company has expanded its R&D facilities, thereby establishing sustainable relevance in the dynamic and growing Global Pharmaceutical Market.